{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:25:55Z","timestamp":1794327955064,"version":"4.9.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>\n                      Cutaneous leishmaniasis (CL), caused by protozoa of the genus\n                      <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                      , is a neglected tropical disease. Limited evidence exists to inform the management of CL in children and adolescents, and experience in non-endemic settings varies significantly. We report case data and treatment outcomes for 17 children and young people diagnosed with CL and treated at a specialist tropical medicine center in the United Kingdom.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The electronic patient records of 17 patients less than 18 years old with CL who were treated at University College London Hospitals between October 2015 and June 2025 were accessed to gather data including demographics (age, sex, country of origin), likely country of CL acquisition, causative species of\n                      <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                      , treatment given and treatment outcome. Causative agents included\n                      <jats:italic toggle=\"yes\">L. donovani<\/jats:italic>\n                      complex (n = 6),\n                      <jats:italic toggle=\"yes\">L. major<\/jats:italic>\n                      (n = 5),\n                      <jats:italic toggle=\"yes\">L. tropica<\/jats:italic>\n                      (n = 4),\n                      <jats:italic toggle=\"yes\">L. Viannia<\/jats:italic>\n                      subgenus (n = 1) and a\n                      <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                      species where subgenus or species could not be determined (n = 1).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Conservative management (2\/17), oral miltefosine (9\/17), intralesional meglumine antimoniate (3\/17) and intravenous liposomal amphotericin B (LAMB; 3\/17) were used as first-line treatment approaches in this cohort. Two patients were lost to follow-up, but complete resolution was observed in 14 of the remaining 15 patients by day 180 post-treatment initiation, with 1 child\u2019s lesion taking longer than this to fully re-epithelialize. Adverse effects of treatment were observed in 6\/17 (35%) patients and were mild or moderate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our data show that miltefosine, intralesional meglumine antimoniate and LAMB are effective, safe and well-tolerated treatments for children with CL in non-endemic settings. Management of children and young adults with CL may present additional complexity compared to adults, such as difficulty obtaining biopsy samples, lack of evidence for drug dosing regimens and tolerability of painful injections, which need to be administered repeatedly. Individualized treatment decisions should be made in conjunction with children, young people and their families, and a multidisciplinary approach is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005318","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:00:10Z","timestamp":1784264410000},"page":"e484-e491","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Study of the Management of Pediatric Cutaneous Leishmaniasis in a Non-endemic Setting"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-3314","authenticated-orcid":false,"given":"Owain","family":"Donnelly","sequence":"first","affiliation":[{"name":"Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom"},{"name":"Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop","family":"Krikorian","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cohen","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Spencer","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0425-8399","authenticated-orcid":false,"given":"Joanna","family":"Martin","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Sen","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-8376","authenticated-orcid":false,"given":"Stephen L.","family":"Walker","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom"},{"name":"Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Department of Dermatology, University College London Hospitals NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Eisen","sequence":"additional","affiliation":[{"name":"Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom"},{"name":"Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom"},{"name":"Children and Young People\u2019s Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom"},{"name":"Institute of Child Health, University College London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"R1-20261110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis.","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"R2-20261110","doi-asserted-by":"crossref","first-page":"e0008001","DOI":"10.1371\/journal.pntd.0008001","article-title":"What constitutes a neglected tropical disease?","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS NeglTrop Dis"},{"key":"R4-20261110","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence.","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"R5-20261110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis.","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"R6-20261110","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R7-20261110","doi-asserted-by":"crossref","first-page":"2002028","DOI":"10.2807\/1560-7917.ES.2022.27.4.2002028","article-title":"Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis.","volume":"27","author":"Van der Auwera","year":"2022","journal-title":"Euro Surveill"},{"key":"R8-20261110","doi-asserted-by":"crossref","first-page":"102903","DOI":"10.1016\/j.tmaid.2025.102903","article-title":"Leishmaniasis in the United Kingdom: experience of a national multidisciplinary team meeting in a non-endemic setting.","volume":"67","author":"Donnelly","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"R9-20261110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tmaid.2004.11.002","article-title":"Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis.","volume":"4","author":"Scarisbrick","year":"2006","journal-title":"Travel Med Infect Dis"},{"key":"R10-20261110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jtm.12089","article-title":"LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.","volume":"21","author":"Blum","year":"2014","journal-title":"J Travel Med"},{"key":"R13-20261110","doi-asserted-by":"crossref","first-page":"e0006986","DOI":"10.1371\/journal.pntd.0006986","article-title":"Interventions to treat cutaneous leishmaniasis in children: a systematic review.","volume":"12","author":"Uribe-Restrepo","year":"2018","journal-title":"PLoS NeglTrop Dis"},{"key":"R14-20261110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/bjd.13496","article-title":"Can a simple outpatient\u2010based treatment be used to treat cutaneous leishmaniasis in young children? A critically appraised topic.","volume":"172","author":"Burden\u2010Teh","year":"2015","journal-title":"Br J Dermatol"},{"key":"R15-20261110","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/INF.0000000000003445","article-title":"Treatment of cutaneous leishmaniasis in a nonendemic country: a case series of children in Australia.","volume":"41","author":"Hill","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20261110","doi-asserted-by":"crossref","first-page":"fmad003","DOI":"10.1093\/tropej\/fmad003","article-title":"Everything old is new again: a case series of pediatric cutaneous leishmaniasis in Portland, Maine.","volume":"69","author":"Jubulis","year":"2023","journal-title":"J Trop Pediatr"},{"key":"R17-20261110","first-page":"adv00322","article-title":"Cutaneous leishmaniasis treated with miltefosine: a case series of 10 paediatric patients.","volume":"100","author":"Ollech","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"R18-20261110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/12034754251355201","article-title":"Pediatric cutaneous leishmaniasis: a case series in a montreal tertiary care hospital.","volume":"30","author":"Aaron","year":"2025","journal-title":"J Cutan Med Surg"},{"key":"R19-20261110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/INF.0000000000001741","article-title":"Successful treatment of disseminated cutaneous leishmaniasis with liposomal amphotericin B and miltefosine in an eight-year-old girl.","volume":"37","author":"Hamzavi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20261110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jaad.2013.12.047","article-title":"Leishmania tropica in children: a retrospective study.","volume":"71","author":"Solomon","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R21-20261110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/tropicalmed10080203","article-title":"Experiences of individuals with cutaneous leishmaniasis receiving intralesional sodium stibogluconate or liquid nitrogen cryotherapy in Addis Ababa, Ethiopia\u2014a cross-sectional study.","volume":"10","author":"Abd El Aziz","year":"2025","journal-title":"Trop Med Infect Dis"},{"key":"R22-20261110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.","volume":"195","author":"Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"R23-20261110","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/ciy747","article-title":"Pharmacokinetics, safety, and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase II clinical trial.","volume":"68","author":"Mbui","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R24-20261110","doi-asserted-by":"crossref","first-page":"e0006141","DOI":"10.1371\/journal.pntd.0006141","article-title":"Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation.","volume":"12","author":"Olliaro","year":"2018","journal-title":"PLoS NeglTrop Dis"},{"key":"R25-20261110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.14-0512","article-title":"Diagnosis of cutaneous leishmaniasis: why punch when you can scrape?","volume":"92","author":"Saab","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"R26-20261110","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","article-title":"Optimal dosing of miltefosine in children and adults with visceral leishmaniasis.","volume":"56","author":"Dorlo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-20261110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jir816","article-title":"Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.","volume":"205","author":"Rubiano","year":"2012","journal-title":"J Infect Dis"},{"key":"R28-20261110","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by leishmania braziliensis in Brazil: a randomized and controlled trial.","volume":"4","author":"Machado","year":"2010","journal-title":"PLoS NeglTrop Dis"},{"key":"R29-20261110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2012.06.014","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.","volume":"68","author":"Solomon","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R30-20261110","doi-asserted-by":"crossref","first-page":"110712","DOI":"10.1016\/j.nut.2019.110712","article-title":"Nutrition, malnutrition, and leishmaniasis.","volume":"73","author":"Nweze","year":"2020","journal-title":"Nutrition"},{"key":"R31-20261110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00439-020-02130-w","article-title":"Human genetics of leishmania infections.","volume":"139","author":"Blackwell","year":"2020","journal-title":"Hum Genet"},{"key":"R32-20261110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pt.2009.05.004","article-title":"The role of host genetics in leishmaniasis.","volume":"25","author":"Sakthianandeswaren","year":"2009","journal-title":"Trends Parasitol"},{"key":"R33-20261110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/ANA.0b013e31826a038d","article-title":"Pediatric anesthesia and neurodevelopmental impairments: a Bayesian meta-analysis.","volume":"24","author":"DiMaggio","year":"2012","journal-title":"J Neurosurg Anesthesiol"},{"key":"R34-20261110","doi-asserted-by":"crossref","first-page":"e0184777","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: a systematic review.","volume":"12","author":"Brito","year":"2017","journal-title":"PLoS One"},{"key":"R35-20261110","doi-asserted-by":"crossref","first-page":"e0007856","DOI":"10.1371\/journal.pntd.0007856","article-title":"Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: a cost-effectiveness analysis.","volume":"13","author":"Brito","year":"2019","journal-title":"PLoS NeglTrop Dis"},{"key":"R36-20261110","doi-asserted-by":"crossref","first-page":"e0007788","DOI":"10.1371\/journal.pntd.0007788","article-title":"\u201cCheaper and better\u201d: societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.","volume":"13","author":"Rodr\u00edguez","year":"2019","journal-title":"PLoS NeglTrop Dis"},{"key":"R37-20261110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions.","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"R38-20261110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/pch\/pxad010","article-title":"The impact of music, play, and pet therapies in managing pain and anxiety in paediatric patients in hospital: a rapid systematic review.","volume":"28","author":"Goren","year":"2023","journal-title":"Paediatr Child Health"},{"key":"R39-20261110","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.pmn.2015.08.004","article-title":"The effect of entonox, play therapy and a combination on pain relief in children: a randomized controlled trial.","volume":"16","author":"Mohan","year":"2015","journal-title":"Pain Manag Nurs"},{"key":"R40-20261110","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med"},{"key":"R41-20261110","doi-asserted-by":"crossref","first-page":"e0007253","DOI":"10.1371\/journal.pntd.0007253","article-title":"Topical paromomycin for new world cutaneous leishmaniasis.","volume":"13","author":"Sosa","year":"2019","journal-title":"PLoS NeglTrop Dis"},{"key":"R43-20261110","doi-asserted-by":"crossref","first-page":"e0006094","DOI":"10.1371\/journal.pntd.0006094","article-title":"Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: not a panacea.","volume":"11","author":"Guery","year":"2017","journal-title":"PLoS NeglTrop Dis"},{"key":"R44-20261110","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis due to leishmania tropica.","volume":"25","author":"Solomon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R45-20261110","doi-asserted-by":"crossref","first-page":"e0004880","DOI":"10.1371\/journal.pntd.0004880","article-title":"Efficacy and safety of ambisome in combination with sodium stibogluconate or miltefosine and miltefosine monotherapy for African visceral leishmaniasis: phase II randomized trial.","volume":"10","author":"Wasunna","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"key":"R46-20261110","doi-asserted-by":"crossref","first-page":"e02198","DOI":"10.1128\/AAC.02198-16","article-title":"Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis.","volume":"61","author":"Castro","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R47-20261110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species.","volume":"64","author":"Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"R48-20261110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(85)90197-X","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs I. Clinical and immunological studies.","volume":"79","author":"Bryceson","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R49-20261110","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1086\/340704","article-title":"Endemic infectious diseases of Afghanistan.","volume":"34","author":"Wallace","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R50-20261110","doi-asserted-by":"crossref","first-page":"102849","DOI":"10.1016\/j.tmaid.2025.102849","article-title":"Leishmaniasis in Syria\u2014a call for action of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Travellers and Migrants (ESGITM) and for Clinical Parasitology (ESGCP).","volume":"66","author":"Abbara","year":"2025","journal-title":"Travel Med Infect Dis"},{"key":"R51-20261110","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1186\/s12889-020-08749-8","article-title":"Migrants\u2019 and refugees\u2019 health status and healthcare in Europe: a scoping literature review.","volume":"20","author":"Lebano","year":"2020","journal-title":"BMC Public Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:01:39Z","timestamp":1794326499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005318","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2025-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}